Provepharm Inc. recalls Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm
Recalled December 25, 2024 · FDA recall D-0150-2025 · Provepharm
Hazard
Discoloration · FDA Class II
Units
2160 packs/5 ampules per pack = 10,800 ampules
Sold at
Nationwide within the United States
Description
Discoloration
Product
Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05
Manufacturer(s)
Provepharm Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →